These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12169042)

  • 21. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
    Antonijoan RM; García-Gea C; Puntes M; Valle M; Esbri R; Fortea J; Barbanoj MJ
    Clin Drug Investig; 2007; 27(7):453-61. PubMed ID: 17563125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of desloratadine in children between 2 and 11 years of age.
    Gupta S; Khalilieh S; Kantesaria B; Banfield C
    Br J Clin Pharmacol; 2007 May; 63(5):534-40. PubMed ID: 17488362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations.
    Brannan MD; Reidenberg P; Radwanski E; Shneyer L; Lin CC; Cayen MN; Affrime MB
    Clin Pharmacol Ther; 1995 Sep; 58(3):269-78. PubMed ID: 7554700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
    Monroe E; Finn A; Patel P; Guerrero R; Ratner P; Bernstein D;
    J Am Acad Dermatol; 2003 Apr; 48(4):535-41. PubMed ID: 12664016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
    Ortonne JP; Grob JJ; Auquier P; Dreyfus I
    Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
    DuBuske L
    Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective, open-label analysis of the population pharmacokinetics of a single 10-mg dose of loratadine in healthy white Jordanian male volunteers.
    Salem II; Najib NM; Idkaidek NM
    Clin Ther; 2010 Feb; 32(2):391-5. PubMed ID: 20206796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Randomized Study on the Bioequivalence of Desloratadine in Healthy Chinese Subjects and the Association of Different Metabolic Phenotypes With UGT2B10 and CYP2C8 Genotypes.
    Niu S; Li Y; Dong W; Xia L; Shen T; Wang J; Wang Q; Zhang T; Zhang M; Liu G; Guo D; Fang Y
    Curr Drug Metab; 2020; 21(13):1031-1039. PubMed ID: 33109037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of Desloratadine and Its Metabolite 3-OH Desloratadine in Human Plasma by LC-MS/MS].
    Zhang K; Zhang XQ; Lu W; Xie HR; He L; Jiang XH; Wang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):783-7, 804. PubMed ID: 26619557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
    Nunes T; Rocha JF; Vaz-da-Silva M; Falcão A; Almeida L; Soares-da-Silva P
    Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Desloratadine Slow-metabolizer Phenotype and Food-dependent Pharmacokinetics of Desloratadine in Healthy Chinese Volunteers.
    Wang T; Zhang K; Li T; He L; Xie H; Jiang X; Wang L
    Clin Drug Investig; 2015 Dec; 35(12):807-13. PubMed ID: 26446005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine.
    Kosoglou T; Salfi M; Lim JM; Batra VK; Cayen MN; Affrime MB
    Br J Clin Pharmacol; 2000 Dec; 50(6):581-9. PubMed ID: 11136297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.
    Noehr-Jensen L; Damkier P; Bidstrup TB; Pedersen RS; Nielsen F; Brosen K
    Eur J Clin Pharmacol; 2006 Jun; 62(6):437-45. PubMed ID: 16770647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults.
    Gupta SK; Kantesaria B; Banfield C; Wang Z
    Br J Clin Pharmacol; 2007 Aug; 64(2):174-84. PubMed ID: 17324243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desloratadine.
    McClellan K; Jarvis B
    Drugs; 2001; 61(6):789-96; discussion 797. PubMed ID: 11398910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.
    Layton D; Wilton L; Boshier A; Cornelius V; Harris S; Shakir SA
    Drug Saf; 2006; 29(10):897-909. PubMed ID: 16970513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.